Emotional arousal has been shown to enhance memory, an effect that is blocked by propranolol suggesting that the noradrenergic system is important in the mechanism action. Because PTSD has as prominent features heightened arousal and distressing memories, the current study was undertaken to examine whether PTSD subjects differed from controls in emotional enhancement of memory. Seventeen subjects with PTSD and 21 controls received either placebo or 40 mg of propranolol prior to exposure to either an emotionally arousing or emotionally neutral, narrated slide story. Recall, measured 1 wk later, for the arousing story was enhanced and this effect was reduced by propranolol. PTSD and control subjects did not differ in the acquisition and retention of memories under emotionally arousing or emotionally neutral conditions, nor were differential effects of propranolol observed between the two groups.
Introduction
The catecholamine system has long been known to mediate responses to stressful situations. Exposure to stressful stimuli results in regional selective increases in norepinephrine turnover in the locus coeruleus, limbic regions (hypothalamus, hippocampus and amygdala) and cerebral cortex (Galvin, 1995 ; Tsuda and Tanaka, 1985) . Additional studies indicate that an increased sense of fear or anxiety associated with stress may be a critical factor in activating these areas (Stone, 1973 ; Tsuda et al., 1986 Tsuda et al., , 1988 . PTSD has been largely described as a disorder of memory with intrusive recollections of the original trauma in the form of recurrent daytime memories, nightmares and flashbacks. These memories often remain vivid throughout the life of the individual, and can be reawakened or triggered by a variety of stimuli (Litz and Keane, 1989 ; McNally et al., 1987 ; Tomb, 1994) . It has been hypothesized that the acquisition of emotional memories relies on the function of two neurobiological systems : (1) the endogenous stress hormones (i.e. the catecholamines epinephrine and norepinephrine), and (2) the amygdaloid complex (Cahill, 1997) . There is con-siderable support for the hypothesis that peripheral stress hormones released during an emotionally arousing event influence memory storage processes for the event Gold et al., 1995 ; McGaugh, 1989) . Evidence strongly suggests that epinephrine and norepinephrine act at β-adrenergic receptors to influence memory (Cahill et al., 1994 ; Cahill and McGaugh, 1996 ; . The brain region most clearly implicated in the influence of epinephrine\norepinephrine on memory is the amygdala complex which has long been believed to be involved with emotional behaviours and with the human hormonal stress response (Dunn and Whitener, 1986 ; Redgate, 1970) . Cahill et al. (1994) studied the role of catecholamines in emotionally influenced memories in human subjects by comparing the effect of β-adrenergic receptor blockade on memory recall for emotionally neutral and emotionally arousing material. Subjects took either a placebo or single 40 mg dose of the β-adrenergic blocking agent propranolol 1 h prior to viewing either an emotionally neutral story or a closely matched, but more emotionally arousing, story. Retention for details of the stories were tested 1 wk later. As expected, placebo subjects showed enhanced retention of the emotional story compared to the retention of the subjects who viewed the neutral story. Propranolol blocked this enhancement but did not affect memory for the neutral story, supporting the hypothesis that enhanced memory associated with arousal states in humans involves activation of central β-adrenergic receptors. In another study (Van Stegeren et al., 1998) , propranolol, but not nadolol (a β-blocker that crosses the blood-brain barrier to a lesser extent) decreased memory for emotional events.
The purpose of the current study was to replicate this finding in normal subjects and further, to examine this phenomenon in patients with PTSD. We hypothesized that PTSD subjects would show an accentuated enhancement of memory with emotional arousal.
Methods
The protocol was approved by the Institutional Review Board at the VA Medical Center. All subjects provided informed consent prior to participation. The project was described as a study of arousal in PTSD in an effort to not bias the subjects in terms of memory. Seventeen male veterans with PTSD from combat exposure in the Korean, Vietnam or Gulf wars were recruited from the Long Beach Veterans Administration Medical Center or a VA PTSD Outpatient Clinic. PTSD diagnosis was according to DSM-IV criteria (APA, 1994) with information collected from a psychiatric interview and review of available medical records. Subjects were not excluded if they met criteria for other Axis I or Axis II disorders which did not appear to impair attention or memory. All PTSD subjects completed the Mississippi Scale to provide a relative measure of PTSD symptoms. Mean scores for the Mississippi Scale were 133p25 indicating the presence of moderate PTSD symptoms. Twenty-one males without any psychiatric disorder (10 veteran, 11 civilian ; based on a psychiatric interview) and not taking any medication were recruited to serve as control subjects. Subjects were excluded from participation in the study if they had a past medical history of chronic obstructive pulmonary disease, asthma, bradycardia, hypotension, or a known sensitivity to propranolol. Subjects were also excluded if they were currently using an oral β-adrenergic blocking agent, a sympathomimetic agent, benzodiazepines, or if they admitted to recreational drug use other than alcohol in the past 3 months. Thirteen of the 17 PTSD subjects were taking psychotropic medication including antidepressants and anticonvulsants. Subjects were sequentially assigned to the story conditions (neutral or arousing story).
Treatment (placebo vs. propranolol) was by random assignment and double blind. Table 1 describes the subject characteristics.
The stimulus materials (11 slides) and narrative scripts were identical to those used in a previous study (Cahill et al., 1995) . Each subject viewed the 11 slides projected sequentially onto a screen measuring 1n1i1n2 m while β-Adrenergic blockade and emotional memory in PTSD 3. The father is the chief laboratory technician at the nearby hospital. 4. They check before crossing a busy road.
4. They check before crossing a busy road. Phase 2 Phase 2 5. While walking along, they pass the scene of a minor accident, which the boy finds interesting.
5. While crossing the road, the boy is struck by a runaway car, which critically injures him. 6. At the hospital, the staff are preparing for a practice emergency drill, which the boy will watch.
6. At the hospital, the staff prepare the emergency room, to which the boy is rushed. 7. All morning long, surgeons practised the standard emergency drill procedures.
7. All morning long, surgeons struggled to save the boy's life. 8. Special make-up artists were able to create realistic looking injuries on actors for the drill.
8. Specialized surgeons were able to successfully reattach the boy's severed legs. Phase 3 Phase 3 9. After the drill, while the father stayed with the boy, the mother left to phone her other child's pre-school.
9. After the surgery, while the father stayed with the boy, the mother left to phone her other child's preschool. 10. Running late, she phones the pre-school to tell them she will soon pick up her child.
10. Feeling distraught, she phones the pre-school to tell them she will soon pick up her child. 11. Heading to pick up her child, she hails a taxi at the number nine bus stop.
11. Heading to pick up her child, she hails a taxi at the number nine bus stop.
one of two versions of a simple story was provided (arousal or non-arousal). Each of the 11 slides was presented for 20 s and was accompanied by a onesentence narrative that had been previously recorded onto audiotape. All subjects viewed the slides under similar conditions in the same quiet, dimly lit room, while sitting approx. 2n4 m from the screen. Both the arousal and non-arousal versions of the narratives were divided into three phases. Phase 1 (slides 1-4) and Phase 3 (slides 9-11) had nearly identical narratives for both the arousal and non-arousal conditions. Phase 2 (slides 5-8) differed only by the introduction of emotionally arousing elements (for the arousal condition only). Table 2 describes the single-sentence narratives that accompanied each slide for both the arousal and nonarousal versions of the study. The narratives for each story were matched as closely as possible for complexity, comprehensibility, grammar and syntactic structure. The narration accompanying the first 4 slides was identical in both the arousal and non-arousal versions, and highly similar for the last 3 slides. The narration differed primarily during the middle 4 slides (Phase 2) of the story.
In both versions of the story, a mother takes her son to visit his father at the hospital where he works as a laboratory technician. In the non-arousal version, the boy witnesses a minor car accident on the way to the hospital. He later watches the hospital staff conduct a practice emergency drill. In the arousal version, the boy is critically injured in an automobile accident, and is rushed to the hospital where surgeons struggle to surgically re-attach his severed legs.
Prior to exposure to the slide show, subjects were screened for bradycardia or hypotension, and were randomly administered, in a double-blinded fashion, a capsule containing either 40 mg of propranolol or placebo. Subjects were asked to swallow the pill with 4-8 fl. oz. of water and instructed to engage in quiet activities until they were called for the slide show 60-90 min later.
Upon arrival for the slide show, subjects were seated in the testing room and connected to an ECG machine using wrist and ankle electrodes for measuring heart rate. Instructions were given to the subjects to pay attention only to the slide show being presented on the screen and the accompanying narrative, and to ignore the recording activities of the two researchers. The subjects were informed that the slide show would last about 5 min. After the lighting was dimmed, the recorded narration and corresponding slides were played sequentially. Heart rate was recorded prior to medication, at the beginning of the slide show and during each phase of the story. Subjects were asked not to discuss the test with anyone else and were instructed to return 7 d later at which time ' physiological measurements ' would be taken and ' a few questions ' would be asked. The research staff declined any attempts by the subjects to discuss the slide material.
Subjects returned 7 d later expecting to have more physiological measurements taken, but instead were first asked what they thought the purpose of the study was, and whether they had experienced recollections of the slide show during the 7-d waiting period. Subjects were asked to recall how many slides they had seen and then, as best they could, details of specific slides. Subjects were then tested for memory retention using a 76-question multiple-choice test as was used in the original study (Cahill et al., 1994) . After the testing was completed all of the subjects ' questions regarding the study were answered. Table 3 and Figures 1 and 2 describe the results of the follow-up memory tests. A multivariate analysis of variance (PTSD or controliarousal stateidrug treatment) was used to analyse the dependent variable : percent correct recall in the three different story phases from the multiple-choice test. A main effect for the drug was observed for Phase 3 (percent correct recall) [F(1,28) l 5n526, p l 0n026]. In addition, a significant interaction between drug and story was observed for story Phases 2 and 3 (percent correct recall) [F(1,28) l 6n925, p l 0n014 and F(1,28) l 8n572, p l 0n007, respectively].
Results
The interactions were further investigated by performing independent sample t tests for story Phases 1-3 (percent correct recall) for subjects in the arousal condition and for subjects in the non-arousal condition. Since the hypothesis predicted the direction of recall scores, an α of 0n05 one-tailed was adopted for all follow-up analysis. Also, the chance of a type I error was controlled by adopting the Bonferroni method and dividing the α of 0n05 by the number of t tests performed for each dependent variable (two).
A main effect for the drug was observed for subjects in the arousal condition in both Phase 2 [t(17) l 2n248, p l 0n019] and Phase 3 [t(17) l 3n737, p l 0n001] but not in Phase 1. In contrast no effect was observed in either of these phases for the non-arousal condition [Phase 2 : t(15) l -1n144, p l 0n136 ; Phase 3 : t(15) l 0n720, p l 0n242].
A mixed design analysis of variance phases as the repeated-measure variable and group associations (PTSD or controliarousal stateidrug treatment) as the between-group variable was used to analyse heart rates. β-Adrenergic blockade and emotional memory in PTSD Since a violation of the assumption of sphericity was observed, the degrees of freedom for all analysis that included the repeated-measure variable were adjusted by multiplying them with the Greenhouse-Geisser ε. A main effect for phase was observed [F(1n834,51n351) l 19n647, p l 0n000]. The starting heart rate was significantly higher than all other heart rates measured in the other phases. A main effect for the drug was also observed [F(1,28) l 9n906, p l 0n004]. Subjects who received propranolol had a lower heart rate than subjects who received the placebo. No other main effects or interactions were observed.
In order to determine if control and PTSD subjects received equivalent propranolol doses, a factorial analysis of variance (PTSD or controliarousal state) was performed on the dosage of propranolol in mg\kg body weight. No statistically significant differences were observed between groups for control or PTSD subjects (F l 0n000, p 0n999) or for arousal state (neutral or emotional stimulus) (F l 1n427, p 0n250) .
A factorial analysis of variance (PTSD or control iarousal stateidrug treatment) was also performed to examine age differences within the groups. The PTSD subjects were significantly older (50n5 yr) than the control group (44n4 yr) (F l 4n59, p 0n040).
Discussion
Our findings of a significant effect of drug and arousal state support the hypothesis of Cahill et al. (1994) . Propranolol had a significant effect on attenuating memory in subjects that viewed the arousal story when all subjects were combined. No differences, however, were observed between PTSD and control subjects for the effect of the story (arousing vs. mental) or medication (placebo vs. propranolol). This suggests that PTSD patients do not have a fundamentally altered relationship between emotional arousal and memory. It must be considered, however, that 13 of the 17 PTSD subjects were on psychotropic medication which may have modified observed responses. In a medication-free state it is conceivable that PTSD subjects would have had a physiologically different response to the arousal condition.
Of interest is that there was a statistically significant increase in the percentage correct recall for Phase 2 of the story when compared to Phases 1 and 3 for all subjects ( p 0n05) regardless of whether they viewed the arousing or neutral story. This implies that regardless of condition, all subjects seemed to respond to our test as though it was an arousal test. In support of this explanation is the observation of elevated heart rate in all subjects prior to receiving medication. This may be related, in part, to the fact that our subjects were told that they were taking part in a ' PTSD ' study. The consent form stated that they may find the slide story upsetting (this was an IRB requirement). It is conceivable that, due to the expectation of being exposed to a ' traumatic ' slide show, subjects were ' aroused ' going into the slide show. In contrast, subjects who took part in the original Cahill et al. (1994) study were told that it was an experiment to test physiological responses to a slide show. In their study, ' emotionally ' ratings were higher on the arousal condition compared to the neutral condition regardless of medication. We assumed that our population would react similarly and did not include emotionality ratings. In retrospect, this would have been useful.
In summary, although we were unable to show significant differences PTSD and control subjects in this specific testing paradigm, propranolol selectively reduced the recall of events in subjects viewing the arousing story.
By modifying the design to remove the possibility of anticipatory arousal in our subjects, it is possible that differences in the phenomenon of emotional memory enhancement between PTSD and control subjects would be revealed. Future studies should also include emotionality ratings to assess the subjective experience of the participant. Additionally, further research using β-blockers with different affinities for β-1 and β-2 receptors and with different abilities to cross the blood-brain barrier might serve to clarify the role of the β-adrenergic system in regulating memory for emotional experiences. For example a recent study has shown that metoprolol, an antagonist to the β-1 receptor reduced recall of emotional events (O 'Carroll et al., 1999) .
The question remains unanswered as to the role of emotional enhancement of memory in the pathophysiology of PTSD. Of interest is the finding of Shalev et al. (1998) that the future development of PTSD in trauma victims was highly correlated with heart rate 1 wk following the trauma. If heart rate is considered a proxy for adrenergic activation, this study raises the possibility that this excess activation contributes to the development of PTSD through enhanced memory consolidation. This then would present an opportunity for early intervention in trauma victims with β-blockers in an effort to prevent development of PTSD.
